Phase 2 Leukemia and Lymphoma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Leukemia RelapseLymphoma Diffuse Large B-cellLeukemia and Lymphoma+1 more

AvenCell Therapeutics, Inc.178 enrolled13 locationsNCT07284433

Recruiting

Phase 1Phase 2

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Relapsed or Refractory B Cell Leukemia and Lymphoma

Affiliated Hospital to Academy of Military Medical Sciences20 enrolled1 locationNCT06834529